{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:49:36Z","timestamp":1792514976690,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Bergen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Bergen 4-Day treatment (B4DT) is a form of concentrated exposure-based cognitive behavioral therapy (CBT) in which patients receive treatment over four consecutive days. Previous studies have shown B4DT to be a promising treatment format for panic disorder (PD), although the long-term stability of treatment gains requires additional study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Aim<\/jats:title>\n            <jats:p>The aim of the current study was to evaluate the longer-term effectiveness of B4DT for patients with panic disorder with or without agoraphobia. This study extends a previously published study by providing a long-term follow-up of the same cohort (<jats:italic>n<\/jats:italic>\u2009=\u200930), initially assessed at three months post-treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method<\/jats:title>\n            <jats:p>Thirty patients with panic disorder were consecutively included in a retrospect open trial. The primary outcome measure was the Panic Disorder Severity Scale. The secondary outcome measures were the Generalized Anxiety Disorder-7 and the Patient Health Questionnaire-9. Outcomes were assessed at pretreatment, posttreatment, 3-month follow-up, and longer-term follow-up (with a mean time of 18 months).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>There was a significant reduction in panic disorder symptoms from pretreatment to longer-term follow-up (d\u2009=\u20095.03, 95% CI [18.55, 21.12] to [1.33, 3.87]). The Panic Disorder Severity Scale (PDSS) mean decreased from 19.83 (SD\u2009=\u20090.64, 95% CI [18.55, 21.12]) before treatment, to 4.37 (SD\u2009=\u20090.64, 95% CI [2.98, 5.76]) post-treatment, followed by further decreases at the 3-month follow-up to a mean of 2.84 (SD\u2009=\u20090.64, 95% CI [1.45, 4.22]), and at the longer-term follow-up to 2.60 (SD\u2009=\u20090.64, 95% CI [1.33, 3.87]). There was no significant difference in symptom severity between the 3-month and 18-month assessments, indicating a sustained improvement (<jats:italic>p<\/jats:italic>\u2009&lt;.001). At the 18-month follow-up, 90% of the patients were classified as being in remission. There were also significant reductions in symptoms of depression (<jats:italic>d\u2009=<\/jats:italic>\u20091.44) and generalized anxiety (<jats:italic>d\u2009=<\/jats:italic>\u20091.62) that were maintained at the longer-term follow-up assessment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The results from the current study indicated that the treatment effects of B4DT are stable over time and that the treatment format appears to be promising for PD. Confirming these preliminary results in rigorous study designs is needed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>The study was approved by the Regional Committee for Medical and Health Research Ethics of Northern Norway (REK Nord-2021\/209619).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12888-025-06527-7","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T15:20:11Z","timestamp":1738941611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The bergen 4-day treatment for panic disorder: a longer-term follow-up"],"prefix":"10.1186","volume":"25","author":[{"given":"Thorstein Olsen","family":"Eide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjarne","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay Morten","family":"Hjelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stian","family":"Solem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Wheaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thr\u00f6stur","family":"Bj\u00f6rgvinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Kvale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"6527_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC2013.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"4","key":"6527_CR2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1001\/archpsyc.63.4.415","volume":"63","author":"RC Kessler","year":"2006","unstructured":"Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2006;63(4):415\u201324.","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"6527_CR3","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s11136-011-0020-7","volume":"21","author":"J Davidoff","year":"2012","unstructured":"Davidoff J, Christensen S, Khalili DN, Nguyen J, IsHak WW. Quality of life in panic disorder: looking beyond symptom remission. Qual Life Res. 2012;21(6):945\u201359.","journal-title":"Qual Life Res"},{"issue":"Suppl","key":"6527_CR4","first-page":"5","volume":"58","author":"MR Liebowitz","year":"1997","unstructured":"Liebowitz MR. Panic disorder as a chronic illness. J Clin Psychiatry. 1997;58(Suppl):5\u20138.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"6527_CR5","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1037\/0022-006X.71.6.1068","volume":"71","author":"JA Kenardy","year":"2003","unstructured":"Kenardy JA, Dow MG, Johnston DW, Newman MG, Thomson A, Taylor CB. A comparison of delivery methods of cognitive-behavioral therapy for panic disorder: an international multicenter trial. J Consult Clin Psychol. 2003;71(6):1068\u201375.","journal-title":"J Consult Clin Psychol"},{"issue":"3","key":"6527_CR6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1037\/0022-006X.68.3.417","volume":"68","author":"NB Schmidt","year":"2000","unstructured":"Schmidt NB, Woolaway-Bickel K, Trakowski J, Santiago H, Storey J, Koselka M, et al. Dismantling cognitive-behavioral treatment for panic disorder: questioning the utility of breathing retraining. J Consult Clin Psychol. 2000;68(3):417\u201324.","journal-title":"J Consult Clin Psychol"},{"issue":"4","key":"6527_CR7","first-page":"Cd011004","volume":"4","author":"A Pompoli","year":"2016","unstructured":"Pompoli A, Furukawa TA, Imai H, Tajika A, Efthimiou O, Salanti G. Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis. Cochrane Database Syst Rev. 2016;4(4):Cd011004.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10063","key":"6527_CR8","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1016\/S0140-6736(16)30381-6","volume":"388","author":"MG Craske","year":"2016","unstructured":"Craske MG, Stein MB. Anxiety Lancet. 2016;388(10063):3048\u201359.","journal-title":"Anxiety Lancet"},{"issue":"4","key":"6527_CR9","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1037\/0022-006X.68.4.556","volume":"68","author":"MW Otto","year":"2000","unstructured":"Otto MW, Pollack MH, Maki KM. Empirically supported treatments for panic disorder: costs, benefits, and stepped care. J Consult Clin Psychol. 2000;68(4):556\u201363.","journal-title":"J Consult Clin Psychol"},{"issue":"3","key":"6527_CR10","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1192\/bjp.2021.148","volume":"221","author":"D Papola","year":"2022","unstructured":"Papola D, Ostuzzi G, Tedeschi F, Gastaldon C, Purgato M, Del Giovane C, et al. Comparative efficacy and acceptability of psychotherapies for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials. Br J Psychiatry. 2022;221(3):507\u201319.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"6527_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12888-020-02679-w","volume":"20","author":"T Bilet","year":"2020","unstructured":"Bilet T, Olsen T, Andersen JR, Martinsen EW. Cognitive behavioral group therapy for panic disorder in a general clinical setting: a prospective cohort study with 12 to 31-years follow-up. BMC Psychiatry. 2020;20(1):259.","journal-title":"BMC Psychiatry"},{"issue":"3","key":"6527_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/jamapsychiatry.2019.3986","volume":"77","author":"EAM van Dis","year":"2020","unstructured":"van Dis EAM, van Veen SC, Hagenaars MA, Batelaan NM, Bockting CLH, van den Heuvel RM, et al. Long-term outcomes of cognitive behavioral therapy for anxiety-related disorders: a systematic review and Meta-analysis. JAMA Psychiatry. 2020;77(3):265\u201373.","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"6527_CR13","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.brat.2013.09.009","volume":"51","author":"AT Gloster","year":"2013","unstructured":"Gloster AT, Hauke C, H\u00f6fler M, Einsle F, Fydrich T, Hamm A, et al. Long-term stability of cognitive behavioral therapy effects for panic disorder with agoraphobia: a two-year follow-up study. Behav Res Ther. 2013;51(12):830\u20139.","journal-title":"Behav Res Ther"},{"issue":"2","key":"6527_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1037\/0022-006X.74.2.377","volume":"74","author":"ME Addis","year":"2006","unstructured":"Addis ME, Hatgis C, Cardemil E, Jacob K, Krasnow AD, Mansfield A. Effectiveness of cognitive-behavioral treatment for panic disorder versus treatment as usual in a managed care setting: 2-year follow-up. J Consult Clin Psychol. 2006;74(2):377\u201385.","journal-title":"J Consult Clin Psychol"},{"key":"6527_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.brat.2017.07.008","volume":"97","author":"LG \u00d6st","year":"2017","unstructured":"\u00d6st LG, Ollendick TH. Brief, intensive and concentrated cognitive behavioral treatments for anxiety disorders in children: a systematic review and meta-analysis. Behav Res Ther. 2017;97:134\u201345.","journal-title":"Behav Res Ther"},{"key":"6527_CR16","doi-asserted-by":"publisher","first-page":"100267","DOI":"10.1016\/j.jadr.2021.100267","volume":"6","author":"KCP Remmerswaal","year":"2021","unstructured":"Remmerswaal KCP, Lans L, Seldenrijk A, Hoogendoorn AW, van Balkom AJLM, Batelaan NM. Effectiveness and feasibility of intensive versus regular cognitive behaviour therapy in patients with anxiety and obsessive-compulsive disorders: a meta-analysis. J Affect Disorders Rep. 2021;6:100267.","journal-title":"J Affect Disorders Rep"},{"issue":"11","key":"6527_CR17","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/da.23204","volume":"38","author":"A Pittig","year":"2021","unstructured":"Pittig A, Heinig I, Goerigk S, Thiel F, Hummel K, Scholl L, et al. Efficacy of temporally intensified exposure for anxiety disorders: a multicenter randomized clinical trial. Depress Anxiety. 2021;38(11):1169\u201381.","journal-title":"Depress Anxiety"},{"issue":"4","key":"6527_CR18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jocrd.2014.08.002","volume":"3","author":"A Havnen","year":"2014","unstructured":"Havnen A, Hansen B, \u00d6st L-G, Kvale G. Concentrated ERP delivered in a group setting: an effectiveness study. J Obsessive-Compulsive Relat Disorders. 2014;3(4):319\u201324.","journal-title":"J Obsessive-Compulsive Relat Disorders"},{"key":"6527_CR19","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.3389\/fpsyg.2019.02500","volume":"10","author":"G Launes","year":"2019","unstructured":"Launes G, Hagen K, Sunde T, \u00d6st LG, Klovning I, Laukvik IL, et al. A Randomized Controlled Trial of Concentrated ERP, Self-Help and Waiting List for obsessive- compulsive disorder: the Bergen 4-Day treatment. Front Psychol. 2019;10:2500.","journal-title":"Front Psychol"},{"key":"6527_CR20","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3389\/fpsyg.2018.01044","volume":"9","author":"B Hansen","year":"2018","unstructured":"Hansen B, Kvale G, Hagen K, Hjelle KM, Solem S, B\u00f8 B, et al. The Bergen 4-Day treatment for panic disorder: a pilot study. Front Psychol. 2018;9:1044.","journal-title":"Front Psychol"},{"issue":"1","key":"6527_CR21","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1186\/s12888-022-04380-6","volume":"22","author":"HM Iversen","year":"2022","unstructured":"Iversen HM, Eide TO, Harvold M, Solem S, Hansen B, Hagen K. The Bergen 4-day treatment for panic disorder: replication and implementation in a new clinic. BMC Psychiatry. 2022;22(1):728.","journal-title":"BMC Psychiatry"},{"key":"6527_CR22","doi-asserted-by":"crossref","unstructured":"Eide TO, Hjelle KM, S\u00e6tre IU, Solem S, Olsen T, Sk\u00f6ld RO et al. The Bergen 4-Day treatment for panic disorder: implementation in a rural clinical setting. Submitted. 2023.","DOI":"10.1186\/s12888-023-04812-x"},{"issue":"3","key":"6527_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1600-0447.2009.01358.x","volume":"120","author":"MK Bohni","year":"2009","unstructured":"Bohni MK, Spindler H, Arendt M, Hougaard E, Rosenberg NK. A randomized study of massed three-week cognitive behavioural therapy schedule for panic disorder. Acta Psychiatr Scand. 2009;120(3):187\u201395.","journal-title":"Acta Psychiatr Scand"},{"key":"6527_CR24","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22\u201333. quiz 4\u201357."},{"issue":"11","key":"6527_CR25","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1176\/ajp.154.11.1571","volume":"154","author":"MK Shear","year":"1997","unstructured":"Shear MK, Brown TA, Barlow DH, Money R, Sholomskas DE, Woods SW, et al. Multicenter collaborative panic disorder severity scale. Am J Psychiatry. 1997;154(11):1571\u20135.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"6527_CR26","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1017\/S0033291722003683","volume":"53","author":"D Papola","year":"2023","unstructured":"Papola D, Ostuzzi G, Tedeschi F, Gastaldon C, Purgato M, Del Giovane C, et al. CBT treatment delivery formats for panic disorder: a systematic review and network meta-analysis of randomised controlled trials. Psychol Med. 2023;53(3):614\u201324.","journal-title":"Psychol Med"},{"issue":"10","key":"6527_CR27","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/da.20532","volume":"26","author":"TA Furukawa","year":"2009","unstructured":"Furukawa TA, Katherine Shear M, Barlow DH, Gorman JM, Woods SW, Money R, et al. Evidence-based guidelines for interpretation of the panic disorder severity scale. Depress Anxiety. 2009;26(10):922\u20139.","journal-title":"Depress Anxiety"},{"issue":"9","key":"6527_CR28","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"issue":"4","key":"6527_CR29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.genhosppsych.2010.03.006","volume":"32","author":"K Kroenke","year":"2010","unstructured":"Kroenke K, Spitzer RL, Williams JB, L\u00f6we B. The Patient Health Questionnaire somatic, anxiety, and depressive Symptom scales: a systematic review. Gen Hosp Psychiatry. 2010;32(4):345\u201359.","journal-title":"Gen Hosp Psychiatry"},{"issue":"10","key":"6527_CR30","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092\u20137.","journal-title":"Arch Intern Med"},{"issue":"1","key":"6527_CR31","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/s12888-022-04101-z","volume":"22","author":"M Brattmyr","year":"2022","unstructured":"Brattmyr M, Lindberg MS, Solem S, Hjemdal O, Havnen A. Factor structure, measurement invariance, and concurrent validity of the Patient Health Questionnaire-9 and the generalized anxiety disorder scale-7 in a Norwegian psychiatric outpatient sample. BMC Psychiatry. 2022;22(1):461.","journal-title":"BMC Psychiatry"},{"key":"6527_CR32","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3389\/fpsyg.2018.00639","volume":"9","author":"B Hansen","year":"2018","unstructured":"Hansen B, Hagen K, \u00d6st LG, Solem S, Kvale G. The Bergen 4-Day OCD treatment delivered in a Group setting: 12-Month Follow-Up. Front Psychol. 2018;9:639.","journal-title":"Front Psychol"},{"issue":"1","key":"6527_CR33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12888-024-05780-6","volume":"24","author":"K Tjelle","year":"2024","unstructured":"Tjelle K, Opstad HB, Solem S, Kvale G, Wheaton MG, Bj\u00f6rgvinsson T, et al. Patient adherence as a predictor of acute and long-term outcomes in concentrated exposure treatment for difficult-to-treat obsessive-compulsive disorder. BMC Psychiatry. 2024;24(1):327.","journal-title":"BMC Psychiatry"},{"key":"6527_CR34","doi-asserted-by":"publisher","first-page":"667167","DOI":"10.3389\/fpsyt.2021.667167","volume":"12","author":"K Tjelle","year":"2021","unstructured":"Tjelle K, Opstad HB, Solem S, Launes G, Hansen B, Kvale G, et al. Treatment adherence as predictor of outcome in concentrated exposure treatment for obsessive-compulsive disorder. Front Psychiatry. 2021;12:667167.","journal-title":"Front Psychiatry"},{"issue":"1","key":"6527_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12888-024-05607-4","volume":"24","author":"B Hansen","year":"2024","unstructured":"Hansen B, Eide TO, Reir\u00e5skag MA, Tjelle KA, Solem S, Hagen K. The Bergen 4-day treatment for social anxiety disorder: a pilot study. BMC Psychiatry. 2024;24(1):145.","journal-title":"BMC Psychiatry"},{"key":"6527_CR36","doi-asserted-by":"publisher","DOI":"10.1201\/9781439821862","volume-title":"Analysis of incomplete Multivariate Data","author":"JL Schafer","year":"1997","unstructured":"Schafer JL. Analysis of incomplete Multivariate Data. 1st ed. New York: Chapman and Hall\/CRC; 1997.","edition":"1"},{"issue":"2","key":"6527_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/16506073.2018.1478447","volume":"48","author":"B Hansen","year":"2019","unstructured":"Hansen B, Kvale G, Hagen K, Havnen A, \u00d6st LG. The Bergen 4-day treatment for OCD: four years follow-up of concentrated ERP in a clinical mental health setting. Cogn Behav Ther. 2019;48(2):89\u2013105.","journal-title":"Cogn Behav Ther"},{"key":"6527_CR38","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3389\/fpsyg.2019.01069","volume":"10","author":"G Launes","year":"2019","unstructured":"Launes G, Laukvik IL, Sunde T, Klovning I, Hagen K, Solem S, et al. The Bergen 4-Day treatment for obsessive-compulsive disorder: does it work in a New Clinical setting? Front Psychol. 2019;10:1069.","journal-title":"Front Psychol"},{"issue":"8","key":"6527_CR39","doi-asserted-by":"publisher","first-page":"e2013249","DOI":"10.1001\/jamanetworkopen.2020.13249","volume":"3","author":"G Kvale","year":"2020","unstructured":"Kvale G, Hansen B, Hagen K, Abramowitz JS, B\u00f8rtveit T, Craske MG, et al. Effect of D-Cycloserine on the effect of concentrated exposure and response Prevention in difficult-to-treat obsessive-compulsive disorder: a Randomized Clinical Trial. JAMA Netw Open. 2020;3(8):e2013249.","journal-title":"JAMA Netw Open"},{"issue":"8","key":"6527_CR40","doi-asserted-by":"publisher","first-page":"e0237061","DOI":"10.1371\/journal.pone.0237061","volume":"15","author":"M Kampman","year":"2020","unstructured":"Kampman M, van Balkom A, Broekman T, Verbraak M, Hendriks GJ. Stepped-care versus treatment as usual in panic disorder: a randomized controlled trial. PLoS ONE. 2020;15(8):e0237061.","journal-title":"PLoS ONE"},{"issue":"1","key":"6527_CR41","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/08039488.2018.1554699","volume":"73","author":"M Svensson","year":"2019","unstructured":"Svensson M, Nilsson T, Johansson H, Viborg G, Perrin S, Sandell R. Psychometric analysis of the Swedish panic disorder severity scale and its self-report version. Nord J Psychiatry. 2019;73(1):58\u201363.","journal-title":"Nord J Psychiatry"},{"issue":"3","key":"6527_CR42","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/cpp.703","volume":"18","author":"LA Wuyek","year":"2011","unstructured":"Wuyek LA, Antony MM, McCabe RE. Psychometric properties of the panic disorder severity scale: clinician-administered and self-report versions. Clin Psychol Psychother. 2011;18(3):234\u201343.","journal-title":"Clin Psychol Psychother"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06527-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-06527-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06527-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T15:14:04Z","timestamp":1747754044000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-025-06527-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6527"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-06527-7","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"15 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study underwent review by the Regional Committee for Medical Research Ethics Northern Norway, REK North (REK Nord-2021\/209619) and received approval from the privacy officer at the institution. Written informed consent was obtained from all participants, who were informed about the voluntary nature of their participation and their right to withdraw from the study without any detrimental impact on their treatment. The research methods adhered to the appropriate guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}